Doxorubicin-loaded PEI-silica Nanoparticles for Cancer Therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박희경 | - |
dc.contributor.author | 백승호 | - |
dc.contributor.author | 이동현 | - |
dc.date.accessioned | 2023-12-01T02:42:01Z | - |
dc.date.available | 2023-12-01T02:42:01Z | - |
dc.date.issued | 2023-11 | - |
dc.identifier.issn | 0304-128X | - |
dc.identifier.issn | 2233-9558 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/68701 | - |
dc.description.abstract | Targeted anticancer drug delivery systems are needed to enhance therapeutic efficacy by selectively delivering drugs to tumor cells while minimizing off-target effects, improving treatment outcomes and reducing toxicity. In this study, a silica-based nanocarrier capable of targeting drug delivery to cancer cells was developed. First, silica nanoparticles were synthesized by the Stöber method using the surfactant cetyltrimethylammonium bromide (CTAB). Increasing the ratio of EtOH in the solvent produced uniformly spherical silica nanoparticles. Washing the nanoparticles removed unreacted residues, resulting in a non-toxic carrier for drug delivery in cells. Upon surface modification, the pH-responsive polymer, polyethyleneimine (PEI) exhibited slow doxorubicin release at pH 7.4 and accelerated release at pH 5.5. By exploiting this feature, we developed a system capable of targeted drug release in the acidic tumor microenvironment. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 한국화학공학회 | - |
dc.title | Doxorubicin-loaded PEI-silica Nanoparticles for Cancer Therapy | - |
dc.type | Article | - |
dc.identifier.doi | 10.9713/kcer.2023.61.4.570 | - |
dc.identifier.bibliographicCitation | Korean Chemical Engineering Research(HWAHAK KONGHAK), v.61, no.4, pp 570 - 575 | - |
dc.identifier.kciid | ART003012253 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 001132517100005 | - |
dc.identifier.scopusid | 2-s2.0-85183551134 | - |
dc.citation.endPage | 575 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 570 | - |
dc.citation.title | Korean Chemical Engineering Research(HWAHAK KONGHAK) | - |
dc.citation.volume | 61 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Silica nanoparticle | - |
dc.subject.keywordAuthor | Drug delivery system | - |
dc.subject.keywordAuthor | Doxorubicin | - |
dc.subject.keywordAuthor | Cancer therapy | - |
dc.subject.keywordAuthor | pH-responsive | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | PH | - |
dc.subject.keywordPlus | TUMOR | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalWebOfScienceCategory | Engineering, Chemical | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.